Diltiazem Side Effects and Clinical Considerations

Introduction to Diltiazem's Adverse Effects

The American College of Cardiology recommends monitoring blood pressure and heart rate regularly during dose titration of diltiazem, due to its potential to cause hypotension and bradycardia 1
Diltiazem's effects on cardiac conduction and contractility create a serious adverse effect profile, including bradycardia, AV block, and worsening heart failure in patients with pre-existing ventricular dysfunction 2, 3

Peripheral edema occurs in 2.4% of patients taking diltiazem, which is dose-related and more common in women, similar to other calcium channel blockers 2, 1
Bradycardia is a significant adverse effect of diltiazem, due to its negative chronotropic effects on SA and AV nodes, with increased risk when combined with beta-blockers 2, 1

The American Heart Association and the American College of Cardiology should be aware that diltiazem can cause hypotension, which is the most common adverse effect requiring clinical attention 1
Worsening heart failure is a significant risk in patients with pre-existing ventricular dysfunction or reduced ejection fraction, with a 17% incidence in hospitalized patients with EF <50% 1
Reduced left ventricular contractility is an intrinsic effect of diltiazem, due to its negative inotropic effects 2, 4

Constipation is a significant adverse effect of diltiazem, particularly in elderly individuals, due to decreased intestinal motility 2, 5
Potential GERD exacerbation is a concern with diltiazem, which can cause noncardiac chest pain through reflux, potentially confounding the clinical picture in cardiac patients 5

Diltiazem is both a CYP3A4 substrate and moderate CYP3A4 inhibitor, creating significant interaction potential, including severe bradycardia risk when combined with ivabradine 2, 1
Enhanced bradyarrhythmias and heart block are risks when diltiazem is combined with beta-blockers 1
Increased drug levels of CYP3A4 substrates, including apixaban, cyclosporine, and simvastatin, are a concern with diltiazem 1

The American College of Cardiology recommends ECG monitoring in patients with conduction system disease taking diltiazem 1
Liver function tests are recommended if clinically indicated, due to the potential for mild elevations of liver enzymes and rare but serious acute hepatic injury 1
Signs and symptoms of heart failure should be monitored in at-risk patients, particularly those with reduced EF, although the specific guideline society recommendation is not provided in this context 1